HomeUpdatesStem Cell Cures › All

All

Blog Post
9/10/2008
Posted by John M. Simpson
The Interstate Alliance on Stem Cell Research, meeting in Baltimore, MD, Tuesday and Wednesday, moved into new territory, opting to develop a model form to be used by states to help certify stem cells have been ethically derived. It was a good decision and exactly the sort of thing the Alliance should do. Adding credibility to the process is the...
Blog Post
9/9/2008
Posted by John M. Simpson
Representatives of 10 state stem cell agencies are meeting today in Baltimore at the fall gathering of the Interstate Alliance on Stem Cell Research.  One key topic on the agenda is intellectual property rights. That may sound arcane, but it's important. Intellectual Property -- IP -- policies determine who owns and controls the scientific...
Blog Post
8/26/2008
Posted by John M. Simpson
I recently obtained a list of the companies which filed letters of intent with the stem cell agency to apply for New Cell Line grants and Disease Planning Team grants. The agency says it regrets that I got it and published it. I don't.  I'm also hearing that at least some companies are happy I did, too. The California Institute for...
News Release
8/22/2008
CONTACT CONTACT: John M. Simpson, 310-392-0522, ext 317; or cell: 310-292-1902
Santa Monica, CA -- Frequently facing difficulties mustering a quorum for meetings, California's stem cell oversight board has five members who showed up for 40 percent or fewer of regular board meetings so far this year, an analysis of attendance records by Consumer Watchdog found. The nonpartisan, nonprofit consumer group said members unable to...
Blog Post
8/21/2008
Posted by John M. Simpson
Only universities and nonprofit research institutions had been eligible to get a piece of California's $6 billion stem cell research program until two rounds of grants awarded in June -- the  New Cell Line Grants and the Disease Team Planning Grants. Only one firm, Novocell, was successful. It received a $50,000 Disease planning grant. That's...
Blog Post
8/13/2008
Posted by John M. Simpson
Plagued yet again by the problem of a lack of a quorum, California's stem cell oversight committee Tuesday evening coped in an unusual way. The board, known as the Independent Citizens Oversight Committee, essentially drafted a member from the audience. Assembling a quorum for the 29-member ICOC is never easy. It's comprised largely of high-...
News Release
7/29/2008
CONTACT CONTACT: John M. Simpson, 310-392-0522, ext. 317
Proposed Regulations Would Curtail Abusive Behavior By Patent Applicants WASHINGTON, DC -- A coalition of consumer advocacy and public interest groups today filed legal papers supporting new U.S. Patent Office (USPTO) rules that would curtail abusive behavior by patent applicants and improve patent quality. The tactics are used frequently by drug...
Blog Post
7/28/2008
Posted by John M. Simpson
The California stem cell agency's Standards Working Group hammered out very thorough ethical guidelines to ensure human embryonic stem cell lines derived with its funds meet the highest ethical standards.  Those rules, after being approved by the oversight committee, went into effect in November 2006. But what about lines that were derived...
Blog Post
7/28/2008
Posted by John M. Simpson
Interested in how the California stem cell agency has so far parceled out $554 million in research grants? The California Institute for Regenerative Medicine (CIRM) has recently posted a useful chart on its website. The grid lists grants by institution and shows the name of the researcher, type of grant and title of the project. With one click on...
Blog Post
7/22/2008
Posted by John M. Simpson
Looking at recent top hires at the California stem cell agency, I'd  been focusing on the fat salaries being paid to the executives. Today  a more troubling trend dawned on me: The California Institute for Regenerative Medicine's inner executive circle is  becoming an Old Boys Club. Consider this:  With the exception of Chief...